PATENT CLAIM ANALYSIS

Application Number: 15761676
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-12
Patent Classification: ["424", "450000"]

Abstract:
The present invention provides improved stable liposomal formulations and method of preparation thereof. The liposomal formulations include liposomes containing a phosphatidylcholine lipid, a sterol, a PEG-lipid, and a taxane, wherein the taxane is docetaxel or a derivative thereof. The liposomal formulations have improved stability and extended shelf-life. The present invention also provides pharmaceutical compositions comprising a liposomal formulation for the treatment of cancer.

Claim (Index 17):
A pharmaceutical composition comprising the liposomal formulation of  claim 1  for treating cancer in a patient in need thereof, wherein the pharmaceutical composition is suitable for parenteral administration.

Metadata:
- Claim Count in Document: 45.0
- Percentile: 90.0
- Lexical Diversity: 1.69048
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15407512', '15253307', '14255637', '15301570', '14208297']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7586957120771817
- 35 USC 102 Novelty (BERT): 0.5229687372532714
- Combined Prediction Score: 0.7351230145947906
- Mean Citation Score: 330.527132
- Max Citation Score: 337.90787
- Similarity Product: 242.2478609484893

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test